Free Trial

Pacific Biosciences of California (PACB) Earnings Date, Estimates & Call Transcripts

Pacific Biosciences of California logo
$1.27 +0.14 (+12.39%)
Closing price 04:00 PM Eastern
Extended Trading
$1.16 -0.11 (-8.27%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pacific Biosciences of California Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 8After Market ClosesEstimated
Actual EPS
(Feb. 13)
-$0.20
Consensus EPS
(Feb. 13)
-$0.20

Pacific Biosciences of California issued Q4 2024 earnings on February 13, 2025, reporting an EPS of -$0.20, which hit the consensus estimate of -$0.20. Quarterly revenue was reported to be $39.22 million, above analyst estimates of $39.20 million. With a trailing EPS of -$1.64, Pacific Biosciences of California's earnings are expected to grow next year, from ($0.72) to ($0.59) per share.

PACB Upcoming Earnings

Pacific Biosciences of California's next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules.

Get Pacific Biosciences of California Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pacific Biosciences of California and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PACB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PACB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Pacific Biosciences of California Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.23-$0.23-$0.23
Q2 20251-$0.22-$0.22-$0.22
Remove Ads

Pacific Biosciences of California Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025
(Estimated)
-------
2/13/2025Q4 2024-$0.20-$0.20--$0.49$39.20M$39.22M
8/7/2024Q2 2024-$0.24-$0.20+$0.04$0.24$40.52M$36.01M
5/9/2024Q1 2024-$0.26-$0.26--$0.23$38.78M$38.81M
2/15/2024Q4 2023-$0.29-$0.27+$0.02-$0.23$57.96M$58.36M
10/30/2023Q3 2023-$0.29-$0.27+$0.02-$0.28$48.76M$55.70M
8/2/2023Q2 2023-$0.32-$0.26+$0.06-$0.24$40.12M$47.57M
5/2/2023Q1 2023-$0.33-$0.31+$0.02-$0.26$34.38M$38.90M

Pacific Biosciences of California Earnings - Frequently Asked Questions

Pacific Biosciences of California has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on PACB's earnings history.

Pacific Biosciences of California updated its FY 2024 earnings guidance on Tuesday, January, 14th. The company issued revenue guidance of $154.0 million-$154.0 million, compared to the consensus revenue estimate of $155.4 million.

In the previous quarter, Pacific Biosciences of California (NASDAQ:PACB) reported ($0.20) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.20). Learn more on analysts' earnings estimate vs. PACB's actual earnings.

The conference call for Pacific Biosciences of California's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Pacific Biosciences of California's latest earnings report can be read online.
Read Transcript

Pacific Biosciences of California (NASDAQ:PACB) has a recorded annual revenue of $154.01 million.

Pacific Biosciences of California (NASDAQ:PACB) has a recorded net income of -$308.65 million. PACB has generated -$1.64 earnings per share over the last four quarters.

Pacific Biosciences of California's earnings are expected to grow from ($0.72) per share to ($0.59) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:PACB) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners